Gilead Sciences (GILD)

Ordinarily, you’ll want to avoid excessively red-stained ideas. Although certain exceptions might be made for these oversold stocks ready for rebound. Certain relevant enterprises may…

Stock Alert: 3 Market Giants on the Brink of Monumental Rallies

By Yiannis Zourmpanos, InvestorPlace Contributor Feb 20, 2024

During stock market ups and downs, identifying the next big players breeding massive value growth potentials is similar to finding a pearl in a vast ice lake.

From Zero to Hero: 7 Stock Losers That Could Turn Things Around in 2024

By Josh Enomoto, InvestorPlace Contributor Feb 19, 2024

Stock turnarounds can happen when you least expect it. And with the opposite scenario imposing a rude awakening, it’s time to at least consider last…

7 Contrarian Biotech Stocks to Consider Amid Sector Weakness

By Josh Enomoto, InvestorPlace Contributor Feb 15, 2024

Last October, life sciences giant Thermo Fisher Scientific (NYSE:TMO) inadvertently laid out the case for contrarian biotech stocks. According to Reuters, the company revealed that…

7 Biotech Stocks Fighting America’s Deadliest Diseases

By Josh Enomoto, InvestorPlace Contributor Feb 8, 2024

Unlike many other market segments, biotech stocks stand out for their direct relevance. For example, investors who typically wager on aerospace and defense plays usually…

3 Top Pharma Stocks to Buy Now: February 2024

By Rick Orford, InvestorPlace Contributor Feb 1, 2024

Take a look at why these three buy-rated pharma stocks could be your ticket to explosive portfolio growth.

Gilead’s Quiet Revolution: Is GILD the Next Big Stock to Soar?

By David Moadel, InvestorPlace Contributor Jan 10, 2024

While Wall Street obsesses over weight-loss drugs, Gilead Sciences is working on life-saving treatments and GILD stock looks ready to rally.

Nasdaq 100 Alert: 7 Undervalued Tech Stocks Ready to Rocket in 2024

By Rich Duprey, InvestorPlace Contributor Jan 3, 2024

The Nasdaq 100 had a banner year. After a disastrous 2022 that saw the tech-laden index lose one-third of its value, it rebounded sharply in…

3 Biotech Stocks to Buy in the TradeSmith ‘Green Zone’

By TradeSmith Research Staff Dec 21, 2023

It's now time to take a look at these three biotech stocks to buy, as each one is currently within TradeSmith's "Green Zone."

Why Is Hookipa Pharma (HOOK) Stock Up 81% Today?

By William White, InvestorPlace Writer Dec 21, 2023

Hookipa Pharma stock is rising higher on Thursday as investors react to a purchase agreement for 15 million shares of HOOK.

Why Is Compugen (CGEN) Stock Up 189% Today?

By William White, InvestorPlace Writer Dec 19, 2023

Compugen stock is up on Tuesday as investors in CGEN shares react to an exclusive licensing agreement with Gilead Sciences.

Next-Gen Biotech: 3 Companies Leading the Charge in Gene Therapy

By Larry Ramer, InvestorPlace Contributor Dec 7, 2023

These three gene therapy stocks should get huge boosts over the long term from the use of gene editing techniques to treat diseases.

7 Healthcare Stocks to invest in for a Healthy Future

By Gabriel Osorio-Mazzilli, InvestorPlace Contributor Oct 20, 2023

Healthcare stocks may be one of the few winning sectors considering today's economic uncertainty and market turns. Here are the winners.

Why Is Assembly Biosciences (ASMB) Stock Up 92% Today?

By William White, InvestorPlace Writer Oct 17, 2023

Assembly Biosciences stock is taking off with heavy trading of ASMB shares after the company announced a new collaboration agreement!

Cancer Drug Approval? 3 Biotech Stocks on the Brink of Breakthroughs

By Larry Ramer, InvestorPlace Contributor Oct 2, 2023

CAR T therapies have major advantages over traditional cancer drugs. Here are three of the best cancer drug stocks set to benefit from CAR T.

GILD Stock Alert: FDA Expands Indications for Gilead Sciences’ Veklury Covid-19 Treatment

By William White, InvestorPlace Writer Aug 24, 2023

Gilead Sciences (GILD) stock is on the move Thursday following additional FDA approval for its Veklury Covid-19 treatment.

The 3 Best Biotech Stocks to Buy in August

By Jeremy Flint, InvestorPlace Contributor Aug 9, 2023

Even as healthcare stocks suffer from post-pandemic fatigue, these three of the best biotech stocks to buy and ride the wave of good news.

Buy Alert: 3 Biotech Stocks Nearing Super Attractive Entry Points

By Joel Baglole, InvestorPlace Contributor Aug 1, 2023

Investors looking to give their portfolio a boost should consider one of these leading biotech names, which are undervalued right now.

The 7 Most Undervalued Nasdaq Stocks to Buy Now: July 2023

By Ian Bezek, InvestorPlace Contributor Jul 19, 2023

The market is soaring, but there is still time to buy these seven undervalued Nasdaq stocks before they head higher.

Gilead Sciences (GILD)

GILD Stock Earnings: Gilead Sciences Beats EPS, Beats Revenue for Q1 2024

Undervalued Icons: 3 Household Names Trading at Steep Discounts

3 Stocks at 52-Week Lows Poised for a Powerful Rebound

Why Is Xilio Therapeutics (XLO) Stock up 168% Today?

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Gilead Sciences (GILD)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

GILD Stock Predictions, Articles, and Gilead Sciences News

Subscriber Sign in